相似文献
1
In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.
Antimicrob Agents Chemother. 1997 May;41(5):1190-2. doi: 10.1128/AAC.41.5.1190.
2
Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
J Antimicrob Chemother. 1996 Oct;38(4):742-4. doi: 10.1093/jac/38.4.742.
3
In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
Antimicrob Agents Chemother. 1994 May;38(5):1071-8. doi: 10.1128/AAC.38.5.1071.
4
In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
Antimicrob Agents Chemother. 1990 Apr;34(4):568-75. doi: 10.1128/AAC.34.4.568.
5
In vitro activity of BAY 12-8039, a new fluoroquinolone.
Antimicrob Agents Chemother. 1997 Jan;41(1):101-6. doi: 10.1128/AAC.41.1.101.
6
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
J Antimicrob Chemother. 1990 Jul;26(1):39-44. doi: 10.1093/jac/26.1.39.
7
Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):77S-82S. doi: 10.1016/0732-8893(89)90070-9.
8
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Chemotherapy. 1993;39(1):32-5. doi: 10.1159/000238970.
9
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
J Antimicrob Chemother. 1989 Mar;23(3):363-71. doi: 10.1093/jac/23.3.363.
10
Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Diagn Microbiol Infect Dis. 1995 Jan;21(1):33-45. doi: 10.1016/0732-8893(94)00087-d.
引用本文的文献
1
Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration.
J Vet Sci. 2008 Sep;9(3):241-5. doi: 10.4142/jvs.2008.9.3.241.
2
Quinolone resistance due to reduced target enzyme expression.
J Bacteriol. 2003 Dec;185(23):6883-92. doi: 10.1128/JB.185.23.6883-6892.2003.
3
Genotypic analysis of Escherichia coli strains from poultry carcasses and their susceptibilities to antimicrobial agents.
Appl Environ Microbiol. 2001 Apr;67(4):1940-4. doi: 10.1128/AEM.67.4.1940-1944.2001.
4
Susceptibilities of Corynebacterium bovis and Corynebacterium amylocolatum isolates from bovine mammary glands to 15 antimicrobial agents.
Antimicrob Agents Chemother. 2000 Dec;44(12):3476-7. doi: 10.1128/AAC.44.12.3476-3477.2000.
5
Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactions.
Antimicrob Agents Chemother. 2000 Dec;44(12):3344-50. doi: 10.1128/AAC.44.12.3344-3350.2000.
6
MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals.
Antimicrob Agents Chemother. 2000 May;44(5):1367-9. doi: 10.1128/AAC.44.5.1367-1369.2000.
7
Effects of enrofloxacin on porcine phagocytic function.
Antimicrob Agents Chemother. 1999 Sep;43(9):2138-43. doi: 10.1128/AAC.43.9.2138.
本文引用的文献
1
Fluoroquinolones in animal health.
J Vet Pharmacol Ther. 1996 Feb;19(1):1-14. doi: 10.1111/j.1365-2885.1996.tb00001.x.
2
Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
J Antimicrob Chemother. 1996 Oct;38(4):742-4. doi: 10.1093/jac/38.4.742.
3
A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America.
J Clin Microbiol. 1994 Mar;32(3):725-31. doi: 10.1128/jcm.32.3.725-731.1994.
4
Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark.
J Clin Microbiol. 1995 Sep;33(9):2435-44. doi: 10.1128/jcm.33.9.2435-2444.1995.
5
Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assay.
Antimicrob Agents Chemother. 1986 Apr;29(4):634-8. doi: 10.1128/AAC.29.4.634.
6
Efficacy of danofloxacin in the therapy of acute bacterial pneumonia in housed beef cattle.
Vet Rec. 1991 Mar 30;128(13):296-300. doi: 10.1136/vr.128.13.296.
Zotero 插件